ARTG 482446NeoGenix XP™ Syringe Anorganic Bone Mineral in Syringe - Dental bone matrix implant, animal-derived
ARTG ID: 482446 · Neoss Australia Pty Ltd · Collagen Matrix Inc · Class III · Started March 13, 2025
Good Name: Neoss Australia Pty Ltd - NeoGenix XP™ Syringe Anorganic Bone Mineral in Syringe - Dental bone matrix implant, animal-derived
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 482446
- Start Date
- March 13, 2025
- Effective Date
- March 13, 2025
- Country
- United States of America
- Address
- 15 Thornton Road, Oakland, NJ, 07436
NeoGenix XP™ Syringe is indicated for: - Augmentation or reconstructive treatment of the alveolar ridge. - Filling of infrabony periodontal defects. - Filling of defects after root resection, apicoectomy, and cystectomy. - Filling of extraction sockets to enhance preservation of the alveolar ridge. - Elevation of the maxillary sinus floor. - Filling of periodontal defects in conjunction with products intended for Guided Tissue Regeneration (GTR) and Guided Bone Regeneration (GBR). - Filling of peri-implant defects in conjunction with products intended for Guided Bone Regeneration (GBR).
Access comprehensive regulatory information for NeoGenix XP™ Syringe Anorganic Bone Mineral in Syringe - Dental bone matrix implant, animal-derived in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 482446 and sponsored by Neoss Australia Pty Ltd, manufactured by Collagen Matrix Inc in United States of America. The device registration started on March 13, 2025.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.